Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-144470
Filing Date
2026-04-07
Accepted
2026-04-07 06:10:28
Documents
131
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K jagx-20251231.htm   iXBRL 10-K 6855507
2 EX-4.51 jagx-ex4_51.htm EX-4.51 158972
3 EX-4.52 jagx-ex4_52.htm EX-4.52 158975
4 EX-10.116 jagx-ex10_116.htm EX-10.116 55905
5 EX-10.117 jagx-ex10_117.htm EX-10.117 55904
6 EX-19.1 jagx-ex19_1.htm EX-19.1 82331
7 EX-21.1 jagx-ex21_1.htm EX-21.1 6208
8 EX-23.1 jagx-ex23_1.htm EX-23.1 11161
9 EX-31.1 jagx-ex31_1.htm EX-31.1 11010
10 EX-31.2 jagx-ex31_2.htm EX-31.2 13085
11 EX-32.1 jagx-ex32_1.htm EX-32.1 6692
12 EX-32.2 jagx-ex32_2.htm EX-32.2 8609
13 GRAPHIC img31428190_0.jpg GRAPHIC 5052
14 GRAPHIC img131700728_0.jpg GRAPHIC 156101
15 GRAPHIC img131700728_1.gif GRAPHIC 42757
16 GRAPHIC img131700728_2.jpg GRAPHIC 19283
  Complete submission text file 0001193125-26-144470.txt   28903676

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT jagx-20251231.xsd EX-101.SCH 3186901
135 EXTRACTED XBRL INSTANCE DOCUMENT jagx-20251231_htm.xml XML 5946118
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36714 | Film No.: 26842854
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)